Ethics. Research. Community.

F.D.A. Approves Eliquis From Bristol and Pfizer

New York Times. 
[Record Source: New York Times]
Eliquis is the third anticlotting medicine to be approved recently and it is expected the backers will aggressively market their products.
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeNews/Magazine Article
LicenseNone (All rights reserved) ©